Latest News

We hold various workshops and in-house events on a quarterly basis, and also introduce new product news from Able Science.

20 - May - 2024

Completing the Supply Agreement with T.MAN Pharma about Propoliz Products

After signing an MOU on February, AbleScience Pharma completed a final exclusive supply contract for propolis products with T.MAN Pharma.

Propolis is widely used as an alternative therapy in Korea for its anti-inflammatory effect, and T.MAN's spray-type product is quite well known through Thai travelers.

It also has high sales in most countries in Asia, including Hong Kong, Singapore, Indonesia, and Malaysia.

Thus, AbleScience Pharma has signed exclusive sales rights for T.MAN's adult spray as well as all propolis products, including kids spray and lozenges.

First of all, AbleScience Pharma is pushing for permission to import adult spray products as health functional foods and aims to launch them in the second half of the year.

https://www.propolizspray.com/product/

01 - July - 2024

CEO, Kim Jong-Hyun, on Focus Interview of LEADERS magazine

The magazine, LEADERS, which presents a catchphrase, ‘High-Definition Magazine for Leaders of Korea’, had an interview with our CEO, Kim Jong-Hyun, as a leader of a rising company in the market for men’s health.

Focusing on our goal, ‘leading the market as a comprehensive solution pharmaceutical company for improving men’s health’, he presented that first we were trying to get ready for a specialized line of health functional foods.

He added that as a first attempt we were preparing the successful launch of Propoliz spray, which is the Asia No. 1 and Thai No. 1 propolis. It is generally used for immunity and protection of the larynx during the change of seasons, so it is always ranked on the must-buy shopping list when traveling to Thailand. Recently we completed the final contract and are preparing to release it in the second half of this year.

Ending the interview, CEO Kim Jong-Hyun said that we hoped customers would remember us as “the first company that men suffering from andropause and infertility could come to mind, from men’s diseases to prevention”

More about that, refer to LEADERS, vol 209, 2024

08 - August - 2023

AbleScience Pharma, Posting Sales Surge Of BPH Treatments, In Two years.

AbleScience Pharma's medicines for Benign Prostatic Hyperplasia (BPH) achieved record-breaking sales last year. There has been a significant increase in interest in AbleScience Pharma, Inc. in the pharmaceutical industry over the past two years, resulting in a remarkable sales increase for its BPH treatments.
Sales of Tam-sable® SR Tablet, Abletamsulosin® SR Tablet (containing tamsulosin hydrochloride), and Finasterine® Tablet (containing finasteride) are rapidly growing, demonstrating their sales power and excellent quality.
AbleScience Pharma has made significant progress in competing with existing market leaders. Benign prostatic hyperplasia is a common condition among men, leading to various urination-related symptoms. Sales of AbleScience Pharma are expected to continue rising due to the growing demand from BPH patients worldwide.

Able Science Pharma stated, "Above all, we prioritize patients' health and comfort, and we will continue to strive to provide better products and services."


25 - July - 2023

Successfully holding the 2nd half of the year workshop for efficient collaborations 25-July 2023

Able Science Pharma held its second-half workshop on July 20-21, 2023. All company members participated to foster a more positive in-house culture and enhance collaboration efficiency. The workshop aimed to boost motivation by sharing improved collaboration and company vision among executives and employees.

During the first session, all members discussed the company's vision and goals. Management explained the long-term objectives and directions, emphasizing the role and significance of achieving these goals to members. This session helped members understand the bigger picture and how their work connects to the company's vision.

In the subsequent session, there were discussions about incentives, which play a crucial role within the sales team. Various ideas and suggestions were shared, not only within the sales team but also among other teams, to explore more effective incentive strategies. This session raised awareness among all members about how their efforts could contribute to the company's performance and how they would be rewarded.

In addition to meetings and discussions, a bowling contest was organized to strengthen fellowship and cooperation among team members. This contest provided an opportunity for team members to get closer to each other and discover various aspects of their colleagues. After the contest, team members had time to communicate freely and foster a positive in-house culture.

Kim Jong-hyun, CEO of AbleScience Pharma, stated, "This workshop is expected to significantly improve the company's environment and work efficiency. We will continue to cultivate a culture of motivation and positive collaboration among our team members through events like this."


04 - July - 2023

Providing a specialized lecture about communication skill to all members in Seoul office, 04-July 2023.
We invited a professional speaker of Korea CS Academy.

Title: What is “Communication skill starting from ME” and knowing about desirable talk


21 - May - 2023

Participating in 15th Spring Symposium of the Korean Society of Urological Ultrasonography as a sponsor, 21 May 2023, at the Sevrance Hospital.


25 - June - 2023

Participating in the KOREADERMA Spring Symposium of the Association of Korean Dermatologists as a sponsor, 23-24 June 2023, at the-K Hotel Seoul, Convention center


22 - March - 2023

All our members, going incentive trip to Danang Vietnam, 16-20 March 2023


29 - March - 2023

Uploading “A-Roban Ointment” in the Blog and Instatoon (Instagram-cartoon) as advertisement


02 - February- 2023

Launching a mupirocin ointment, “A-Roban”

AbleScience Pharma has released a new antibiotic, "A-Roban Ointment," containing mupirocin. A-Roban ointment is a topical antibiotic generally used to prevent bacterial growth and promote wound healing in cases of skin damage, such as small cuts, scratches, and minor burns.

A-Roban ointment is available over-the-counter at pharmacies and can be applied 1-2 times a day to the wounded area, for several days to weeks depending on the severity of the lesion. It is widely used for skin infections like abscesses and impetigo. A-Roban ointment, containing mupirocin, is a more recent addition to antibiotic topicals and is known for its low resistance rate against Staphylococcus sp. bacteria, which commonly cause skin infections (Reference 1).

Reference:
Jung MY, Chung JY, Lee HY, Park J, Lee DY, Yang JM. Antibiotic Susceptibility of Staphylococcus aureus in Atopic Dermatitis: Current Prevalence of Methicillin-Resistant Staphylococcus aureus in Korea and Treatment Strategies. Ann Dermatol. 2015 Aug;27(4):398-403.
AbleScience Pharma's official statement: "A-Roban is an antibiotic ointment that can help avoid the side effects of topical steroids used for general wound treatment. It's a great choice if you are concerned about the side effects of topical steroids."